Antiviral agent. Specifically suppresses influenza A and B viruses associated with severe acute respiratory syndrome.
In terms of the mechanism of antiviral action it refers to fusion inhibitors (fusion), interacts with hemagglutinin of the virus and prevents fusion of lipid shell of the virus and cell membranes. It has a moderate immunomodulatory effect.
It has interferon-inducing activity, stimulates humoral and cellular immune reactions, phagocytic function of macrophages, increases resistance of the body to viral infections. It reduces the frequency of complications associated with viral infections, as well as exacerbations of chronic bacterial diseases.
Therapeutic effectiveness in viral infections is shown in reduction of general intoxication and clinical manifestations, shortening of the duration of illness, reduction of the risk of complications.
It is classified as low-toxic compound (LD50 >4 g/kg). It does not have any negative effect on human body when administered orally in recommended doses.
Prevention and treatment in adults and children: influenza A and B, acute respiratory infections, severe acute respiratory syndrome (including those complicated by bronchitis, pneumonia); secondary immunodeficiency states; complex therapy of chronic bronchitis, pneumonia and recurrent herpes infection.
Prevention of postoperative infectious complications and normalization of the immune status.
The complex therapy of acute intestinal infections of rotavirus aetiology in children over 3 years old.
Filmed film-coated white to white with a cream color, round, biconvex, rough, white to white with a greenish-yellowish or creamy color on the fracture.
1 tablet umiphenovir hydrochloride 100 mg
Lactose monohydrate – 0.1722 g,
povidone K25 (polyvinyl-pyrrolidone medium molecular) – 0.0064 g,
crospovidone – 0.0094 g,
colloidal silicon dioxide (aerosil) – 0.009 g,
magnesium stearate – 0.003 g.
Composition of the film coating:
Opadray II white [lactose monohydrate – 36%, hypromellose – 28%, titanium dioxide – 26%, macrogol-4000 (polyethylene glycol 4000) – 10%] -0.012 г.
Directions for use
Ingestion, before meals.
Daily dose (depending on age):
Price dose of the drug
from 3 to 6 years old
50 mg (1 50 mg tablet)
6 to 12 years
100 mg (2 tablets of 50 mg or 1 tablet of 100 mg)
older than 12 years and adults
The drug regimen <
In children from 3 years and adults:
Non-specific prophylaxis during epidemics of influenza and other SARS
in a single dose 2 times a week for 3 weeks.
Non-specific prophylaxis in direct contact with patients with influenza and other acute respiratory infections
In a single dose once a day for 10-14 days.
The treatment of influenza and other acute respiratory infections
a day (every 6 hours) for 5 days.
Comprehensive therapy of chronic bronchitis, pneumonia and recurrent herpes infection
In a single dose 4 times a day (every 6 hours) for 5-7 days, then a single dose 2 times a week for 4 weeks.
Prevention of postoperative infectious complications
in a single dose 2 days before surgery, then on the 2nd and 5th day after surgery.
It does not exhibit central neurotropic activity and can be used in medical practice for prophylactic purposes in practically healthy persons of various professions, including those requiring increased attention and coordination of movements (transport drivers, operators, etc.).
Children under 3 years of age; hypersensitivity to umifenovir.
Rare: allergic reactions.
Arbidol, Arbidol Maximum, Arpeflu, Umifenovir
2 years. Do not use after the expiration date printed on the package.
|Conditions of storage|
At a temperature not higher than 25 ° C. Keep out of reach of children.
Buy Afludol, 100 mg 40 pcs. with delivery to USA, UK, Europe and over 120 other countries.